TRT, clomiphene, and fertility: what the evidence actually supports

What's this video probably claiming?

Based on the caption, this creator is walking through a well-worn argument in men's health circles: exogenous testosterone shuts down the hypothalamic-pituitary-gonadal (HPG) axis, suppressing luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn tanks intratesticular testosterone and sperm production. The proposed solution involves clomiphene citrate and human chorionic gonadotropin (hCG) as fertility-preserving alternatives or adjuncts. The framing, "balance, not trade-offs," suggests this creator is positioning these options as a cleaner, more complete approach to male hormone optimization. That framing is partially defensible but glosses over some important clinical nuance. The Endocrine Society guideline citation is a good sign, though the caption cuts off mid-source, which raises questions about how carefully that reference was actually read.

What does the science actually show?

The core mechanism is accurate. Exogenous testosterone does suppress LH and FSH through negative feedback, and intratesticular testosterone, which is required for spermatogenesis, drops sharply. Jarow et al. documented azoospermia or severe oligospermia in a significant proportion of men on exogenous testosterone. Clomiphene citrate, a selective estrogen receptor modulator, blocks estrogen feedback at the hypothalamus and pituitary, increasing LH and FSH output and raising endogenous testosterone. A 2003 study by Guay et al. in the Journal of Andrology showed clomiphene raised total testosterone in hypogonadal men, and more recent work by Ramasamy et al. (2014, Journal of Urology) confirmed it can maintain or improve semen parameters. hCG mimics LH, directly stimulating Leydig cells to produce intratesticular testosterone. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that hCG at doses around 250 IU every other day could maintain intratesticular testosterone even during testosterone suppression. The science here is real. The question is whether the creator is overstating how reliably these interventions work across all patients.

Where does the social media noise diverge from clinical reality?

Here is where things get slippery. Clomiphene is not FDA-approved for male hypogonadism. It is used off-label, and response rates vary considerably. Some men experience mood changes, visual disturbances, or simply inadequate testosterone elevation on clomiphene alone. It also does not work well in men with primary hypogonadism, where the testes themselves are the problem, not the signaling. The "natural testosterone" framing that circulates on TikTok implies clomiphene is always a superior or equivalent alternative to TRT. That is not supported by comparative efficacy data. Additionally, hCG alone or as an adjunct is effective for fertility preservation, but it is not a simple swap for testosterone therapy in men with significant hypogonadism symptoms. The 2018 Endocrine Society guideline does recommend against routine testosterone therapy in men who want to preserve fertility, and does acknowledge clomiphene and hCG as options, but with caveats the caption conveniently omits. Framing these as the "future" of hormone therapy oversells the current evidence base.

What should you actually know?

If you are a man considering TRT and fertility is a concern, this conversation is worth having with a urologist or reproductive endocrinologist, not a TikTok creator. The options are real. Clomiphene can raise testosterone and preserve fertility signaling in the right patient profile, specifically men with secondary hypogonadism and intact testicular function. hCG can be added to a TRT protocol to maintain testicular size and intratesticular testosterone. Coviello's data and subsequent clinical practice support that approach. But none of these are one-size-fits-all solutions, and the evidence for long-term efficacy and safety of clomiphene in men remains thinner than the evidence supporting testosterone therapy for hypogonadism. A semen analysis before and during any hormone intervention is standard of care if fertility matters to you. The framing in this video is not wrong enough to be dangerous, but it is optimistic enough to mislead men into thinking they have simple, equivalent options when the clinical picture is more complicated.